| 产品详情 |
| Edit |   |
|---|
| Product Name | FGF9, Recombinant, Human |
|---|
| Description | Purity ~95% (SDS-PAGE). FGF-9 is both an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cells. FGF-9 induces osteoblast proliferation and new bone formation in a bone organ assay. FGF-9 is produced by many prostate cancer cells and contributes to prostate cancer-induced new bone formation. Also, it may participate in the osteoblastic progression of prostate cancer in bone. It is also an autocrine and/or paracrine neurotrophic factor that promotes the survival of motoneurons and upregulates choline acetyl-transferase activity. FGF-9 enhances survival of AChE-positive neurons and increases their mean soma size. It also up-regulates their choline acetyltransferase activity as potently as NGF and the effect is greater than that elicited by bFGF, CNTF, or GDNF. FGF-9 acts as a survival factor for neurons but does not promote neurite outgrowth. FGF-9 has been shown to mediate its effects by binding to FGF receptors. It efficiently activates the FGFR2c splice form of FGFR2 and the FGF |
|---|
| Size | 50ug |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | FGF9, Recombinant, Human (FGF-9, Glia-Activating Factor, GAF, Heparin-Binding Growth Factor 9, HBGF-9, Fibroblast Growth Factor 9) |
|---|
| Gene, Accession, CAS # | SwissProt: P31371 |
|---|
| Catalog # | 500008 |
|---|
| Price | |
|---|
| Order / More Info | FGF9, Recombinant, Human from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|